You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Drug Therapy, Other

:

Citations 481-490 of 1036 total displayed.

Past content (since Mar 1998):

Editorials
Next-Generation Drug-Eluting Stents: A Spirited Step Forward or More of the Same
Manesh R. Patel; David R. Holmes Jr
JAMA 2008; 299: 1952-1953. [Extract] [Full text] [PDF]  

Editorials
Medicare Part D: A Successful Start With Room for Improvement
Dana P. Goldman; Geoffrey F. Joyce
JAMA 2008; 299: 1954-1955. [Extract] [Full text] [PDF]  

Editorials
Preserving Confidentiality in the Peer Review Process
Catherine D. DeAngelis; Joseph P. Thornton
JAMA 2008; 299: 1956. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Critics Say FDA’s Off-Label Guidance Allows Marketing Disguised as Science
Mike Mitka
JAMA 2008; 299: 1759-1761. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Guideline: Dementia Drugs’ Benefits Uncertain
Rebecca Voelker
JAMA 2008; 299: 1763. [Extract] [Full text] [PDF]  

Letters
Demographic Characteristics and Opioid Prescribing
Jeffrey T. Berger
JAMA 2008; 299: 1773-a-1774-a. [Extract] [Full text] [PDF]  

Letters
Demographic Characteristics and Opioid Prescribing
Nancy N. Maserejian; John B. McKinlay
JAMA 2008; 299: 1773. [Extract] [Full text] [PDF]  

Letters
Demographic Characteristics and Opioid Prescribing—Reply
Mark J. Pletcher; Michael A. Kohn; Ralph Gonzales
JAMA 2008; 299: 1774. [Extract] [Full text] [PDF]  

Original Contributions
Efficacy and Safety of Pyridoxal 5'-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The MEND-CABG II Randomized Clinical Trial
MEND-CABG II Investigators*
JAMA 2008; 299: 1777-1787. [Abstract] [Full text] [PDF]  

Original Contributions
Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction: The MULTISTRATEGY Randomized Trial
Marco Valgimigli; Gianluca Campo; Gianfranco Percoco; Leonardo Bolognese; Corrado Vassanelli; Salvatore Colangelo; Nicoletta de Cesare; Alfredo E. Rodriguez; Maurizio Ferrario; Raul Moreno; Tommaso Piva; Imad Sheiban; Giampaolo Pasquetto; Francesco Prati; Marco S. Nazzaro; Giovanni Parrinello; Roberto Ferrari; for the Multicentre Evaluation of Single High-Dose Bolus Tirofiban vs Abciximab With Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study (MULTISTRATEGY) Investigators
JAMA 2008; 299: 1788-1799. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104

 Collections
 •Sign up for Topic Collection Alerts
 • Show Drug Therapy, Other
 collections from JAMA & Archives Journals.
 •Topic Collections Home
 •Related collections:
  •Drug Therapy
  •Adherence
  •Adverse Effects
  •Medication Error
  •Pediatric Dosing
  •Drug Therapy, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.